1-4 of 4 results for subject:PowderJect
Librarians' tools
- Search time
- 0.169 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:PowderJect
- We searched for
- subject_t:PowderJect OR subject_t:"Powder Ject" OR subject_t:"PowderJect Pharmaceuticals" OR subject_ses:61760
Session
X
2002-03
Type
+
Members' contributions (1)
-
Business questions (1)
+
Parliamentary committees (1)
+
Committee proceedings (1)
-
Select Committee oral evidence (1)
+
Parliamentary papers (1)
-
House of Commons papers (1)
+
Parliamentary proceedings (1)
+
Debates (1)
+
Committee proceedings (1)
-
Select Committee oral evidence (1)
+
Parliamentary questions (3)
-
Business questions (1)
-
Written questions (2)
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what discussions his Department has had with companies involved in the bidding process for contracts to supply (a) smallpox vaccines and (b) TB vaccines; and whether Dr Paul Drayson was referred to.
To ask the Secretary of State for Health, what discussions his Department has had with companies involved in the bidding process for contracts to supply (a) smallpox vaccines and (b) TB vaccines; and whether Dr Paul Drayson was referred to.
Asked by
Liam Fox
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
9 April 2003
For answer on
8 September 2003
Answered on
8 September 2003
Dr. Fox: To ask the Secretary of State for Health what discussions his Department has had with companies involved in the bidding
process for contracts to supply (a) smallpox vaccines and (b) TB vaccines; and whether Dr. Paul Drayson was referred to. [109092]
Mr. Hutton: The Department awarded a contract for the supply of smallpox vaccine on 11 April 2002. Prior to this, officials from the
Department met with Powderject on 22 January 2002 as part of confidential discussions held with the five major pharmaceutical
companies known to have smallpox vaccine manufacturing capability.
The meeting was to inform the companies of our requirements for smallpox vaccine and to find out whether the company was in a
position to meet our requirements and if so, to invite them to submit their written proposals for vaccine supply. Since the award of
the contract to Powderject, there were regular ad hoc meetings between officials from the Department and the Ministry of Defence
with Powderject to resolve matters of detail concerning labelling and packaging and delivery of the vaccine. As all discussions with
the company were confidential, the names of those present can not be revealed in accordance with normal policy.
The Department will shortly be completing a second tranche of smallpox procurement. On 10 January 2003, officials from the
Department met with representatives of all companies who had expressed an interest in bidding for the contract. An adjudication
meeting was held on 12 May 2003 with representatives of two companies whose bids met the criteria for supply. On 30 July, the
Government announced its intention to award the contract to Aventis Pasteur MSD. It is regarded as best practice, for reasons of
commercial confidentiality, that the names of those unsuccessful companies who submitted bids are not revealed.
The Department has had no discussions with companies involved in the bidding process for BCG and Tuberculin PPD. These contract
negotiations are dealt with by the NHS Purchasing and Supply Agency on behalf of the Department.
Subjects
Contracts; Companies; Procurement; Vaccination; Tuberculosis; PowderJect; Smallpox
Date
8 September 2003
Reference
109092; 410 c13W
House
House of Commons
To ask the Secretary of State for Health, when (a) ministers and (b) officials in his Department have met representatives of Powderject; and who was present at each meeting.
To ask the Secretary of State for Health, when (a) ministers and (b) officials in his Department have met representatives of Powderject; and who was present at each meeting.
Asked by
Liam Fox
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
9 April 2003
For answer on
17 June 2003
Answered on
17 June 2003
Dr. Fox: To ask the Secretary of State for Health when (a) Ministers and (b) officials in his Department have met representatives of
PowderJect; and who was present at each meeting. [109076]
Mr. Hutton: Ministers have had no meetings with PowderJect representatives to discuss the placing of the smallpox vaccine contracts.
Officials met with representatives from PowderJect on the following dates: 16 October 2000; 9 January 2001; 22 January 2002; 11
April 2002; 16 July 2002, 5 August 2002; 14 October 2002; 5 December 2002; 10 January 2003; and 29 January 2003.
The Departmental officials and PowderJect representatives present at each meeting was dependent on the subject to be discussed. As
all discussions were confidential, the names of those present are not being revealed. This is in accordance with normal policy.
Subjects
Vaccination; PowderJect; Smallpox
Date
17 June 2003
Reference
109076; 407 c162W
House
House of Commons
Business question on PowderJect and political donations.
Business question on PowderJect and political donations.
Member
Lord Bellingham
(Conservative)
Type
Business questions
Subjects
Finance; Donors; Political parties; Vaccination; PowderJect; Smallpox
Date
3 April 2003
Reference
402 c1096
Chamber / Committee
House of Commons chamber
House
House of Commons
Type
House of Commons papers; Select Committee oral evidence;
Parliamentary committees
Committee
Science and Technology Committee
Subjects
Chemical and biological warfare; Terrorism; Research; Science; PowderJect; Department of Health; Association of the British Pharmaceutical Industry; GlaxoSmithKline; Dstl; Police Scientific Development Branch; Acambis
Commons Library location
CS 902
Date
2 April 2003
Reference
HC 415-ii 2002/03
House
House of Commons